Legislation watch

Search all years.

2019 Senate Concurrent Resolution 14: Halt action limiting new cancer treatment to big hospitals
Introduced by Sen. Curt VanderWall (R) on October 30, 2019
To disapprove (meaning halt) a proposed "final action" by a state “Certificate of Need Commission” that would empower this entity to determine which health care facilities may provide a new Immune Effector Cell Therapy (IECT) treatment to cancer patients. This commission is comprised of incumbent medical service providers, and must give approval before a prospective new medical service provider can open a new clinic or hospital, and before for existing providers can invest in new facilities or acquire certain expensive diagnostic or other tools. This power has generally not been applied to new therapies. The CON law authorizes a legislative body with the ranking minority and majority health policy committee members to halt a commission action.   Official Text and Analysis.
Passed by voice vote in the Senate on October 30, 2019 To disapprove (meaning halt) a proposed "final action" by a state “Certificate of Need Commission” that would empower this entity to determine which health care facilities may provide a new Immune Effector Cell Therapy (IECT) treatment to cancer patients. This commission is comprised of incumbent medical service providers, and must give approval before a prospective new medical service provider can open a new clinic or hospital, and before for existing providers can invest in new facilities or acquire certain expensive diagnostic or other tools. This power has generally not been applied to new therapies. The CON law authorizes a legislative body with the ranking minority and majority health policy committee members to halt a commission action, which had not happened before this vote.
Received in the House on October 30, 2019
Passed by voice vote in the House on October 30, 2019

Comments